Cargando…

Recent advances in pharmacological treatment of heart failure

BACKGROUND: Over the last years, several trials offered new evidence on heart failure (HF) treatment. DESIGN AND RESULTS: For HF with reduced left ventricular ejection fraction, type 2 sodium—glucose cotransporter inhibitors, aside from sacubitril—valsartan, demonstrated extraordinary efficacy in am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iacoviello, Massimo, Palazzuoli, Alberto, Gronda, Edoardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596398/ https://www.ncbi.nlm.nih.gov/pubmed/34043809 http://dx.doi.org/10.1111/eci.13624

Ejemplares similares

Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development
por: Gronda, Edoardo, et al.
Publicado: (2020)

Does the Measurement of Ejection Fraction Still Make Sense in the HFpEF Framework? What Recent Trials Suggest
por: Palazzuoli, Alberto, et al.
Publicado: (2023)

Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence
por: Palazzuoli, Alberto, et al.
Publicado: (2022)

Renal Oxygen Demand and Nephron Function: Is Glucose a Friend or Foe?
por: Gronda, Edoardo, et al.
Publicado: (2023)

The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
por: Gronda, Edoardo, et al.
Publicado: (2020)

The Benefit of Sodium-Glucose Co-Transporter Inhibition in Heart Failure: The Role of the Kidney
por: Gronda, Edoardo, et al.
Publicado: (2022)

ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes
por: Gronda, Edoardo, et al.
Publicado: (2021)

Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
por: Gronda, Edoardo G., et al.
Publicado: (2022)

Sympathetic activation in heart failure( )
por: Gronda, E, et al.
Publicado: (2022)

Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction
por: Gronda, Edoardo, et al.
Publicado: (2017)

Recent advances in treatment of heart failure
por: Kitai, Takeshi, et al.
Publicado: (2015)

The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines
por: Beltrami, Matteo, et al.
Publicado: (2022)

Recent advances in the treatment of chronic heart failure
por: Buckley, Leo F, et al.
Publicado: (2019)

Cardiac congestion assessed by natriuretic peptides oversimplifies the definition and treatment of heart failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Use of Levosimendan in Patients with Advanced Heart Failure: An Update
por: Masarone, Daniele, et al.
Publicado: (2022)

Pulmonary Congestion Assessment in Heart Failure: Traditional and New Tools
por: Pirrotta, Filippo, et al.
Publicado: (2021)

Vericiguat in Heart Failure: Characteristics, Scientific Evidence and Potential Clinical Applications
por: Vannuccini, Francesca, et al.
Publicado: (2022)

Heart failure in elderly: progress in clinical evaluation and therapeutic approach
por: Iacoviello, Massimo, et al.
Publicado: (2013)

Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature
por: Palazzuoli, Alberto, et al.
Publicado: (2023)

Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney
por: Palazzuoli, Alberto, et al.
Publicado: (2015)

Glucagon and heart in type 2 diabetes: new perspectives
por: Ceriello, Antonio, et al.
Publicado: (2016)

Modern Approaches for the Treatment of Heart Failure: Recent Advances and Future Perspectives
por: Popa, Irene Paula, et al.
Publicado: (2022)

Recent Advances in Pharmacology
Publicado: (1951)

Metabolic Regulation in the Development of Cardiovascular Disease and Heart Failure
por: Iacoviello, Massimo
Publicado: (2023)

Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart Failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Recent Advances in Pharmacology
Publicado: (1970)

Reappraisal on pharmacological and mechanical treatments of heart failure
por: Liang, Bo, et al.
Publicado: (2020)

Recent Advances in Microbiota-Associated Metabolites in Heart Failure
por: Masenga, Sepiso K., et al.
Publicado: (2023)

Recent advances in pharmacological treatment of neuropathic pain
por: Finnerup, Nanna Brix, et al.
Publicado: (2010)

Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care
por: Palazzuoli, Alberto, et al.
Publicado: (2023)

In-hospital Routes of Acute Heart Failure Admissions During COVID-19
por: Ruocco, Gaetano, et al.
Publicado: (2020)

Heart Failure: An Exploration of Recent Advances in Research and Treatment
por: Shoucri, Rachad, et al.
Publicado: (2016)

Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection
por: Caricati-Neto, Afonso, et al.
Publicado: (2019)

Risk Factors and Cellular Differences in Heart Failure: The Key Role of Sex Hormones
por: Delcuratolo, Elvira, et al.
Publicado: (2023)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

The Role of Genetics in the Management of Heart Failure Patients
por: Palmieri, Gianpaolo, et al.
Publicado: (2023)

Recent Advances in the Pharmacology of Tardive Dyskinesia
por: Caroff, Stanley N.
Publicado: (2020)

Pharmacology of Adenosine Receptors: Recent Advancements
por: Vincenzi, Fabrizio, et al.
Publicado: (2023)

Heart Failure: An Exploration of Recent Advances in Research and Treatment (A)
por: Szema, Anthony, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4i0bfah3fuqqvei9vcpq07qumk